Biosimilar Antibody IgG1
Catalog-Number:
BCMCB1
Description
BiCell Biosimilar Antibody IgG1
The BiCell Biosimilar Antibody IgG1 is a cutting-edge therapeutic product, designed to closely mimic the molecular structure and efficacy of an original monoclonal antibody. This biosimilar offers a high-quality, cost-effective alternative for various therapeutic applications.
Key Features
- High Fidelity: Engineered to ensure structural and functional similarity to the reference antibody.
- Enhanced Stability: Formulated for improved stability and extended shelf life.
- Reduced Immunogenicity: Modified to minimize immune system reactions.
- Versatile Applications: Suitable for a range of therapeutic areas, including oncology, autoimmunity, and inflammatory diseases.
Applications
The BiCell Biosimilar Antibody IgG1 is designed for therapeutic use in a wide array of medical conditions. Its applications include, but are not limited to, targeted cancer therapy, treatment of autoimmune diseases, and management of chronic inflammatory conditions.
| Clonality: | Monoclonal |
|---|---|
| Concentration: | 0.25 mg/ml |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Purification: | Affinity Chromatography |
| Reactivity: | Human |